Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01628315 · ClinicalTrials.gov registry record
Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 159
- Enrollment target
NCT01628315: Completed study, sponsored by University at Buffalo.
NCT01628315 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 159 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01628315 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
Study Summary
* To examine short- and long-term value of appearance of new active lesions in predicting extent of cortical and subcortical deep gray matter (SDGM) atrophy over 5 years in ASA (Avonex- Steroid-Azathioprine)study. * To explore how accumulation of cortical and SDGM atrophy over 5 years differs with respect to the number of new active lesions or amount of disease activity, in early relapsing-remitting multiple sclerosis (RRMS) patients who did or did not develop sustained disability progression. * To examine the relationship between development of cortical and SDGM atrophy and regional likelihood of development of new active lesions over 5 years.
Primary Outcome
Assessment of lesion activity in the 0-6 and 6-12 months in the ASA study will allow the classification of patients with respect to the number of new active lesions over short-term (over 1 year) in order to examine predictive value of MRI disease activity in relation to development of long-term (5 year) cortical and SDGM atrophy.
Interventions
- DEVICE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-12 |
What the finished NCT01628315 record still lists
NCT01628315 is an observational study that tracks outcomes without assigning an intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01628315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01628315 about?
NCT01628315 is a clinical study titled "Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study". * To examine short- and long-term value of appearance of new active lesions in predicting extent of cortical and subcortical deep gray matter (SDGM) atrophy over 5 years in ASA (Avonex- Steroid-Azathioprine)study. * To explore how accumulation of cortical and SDGM atrophy over 5 years differs with r...
What is the current status of trial NCT01628315?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2009-03. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01628315?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT01628315?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia